Mitchell H. Sokoloff, MD

Faculty Listing
Urology

Last updated:

Please send comments or questions to
webmaster@surgery.arizona.edu

Mitchell H. Sokoloff, MD
Professor of Surgery
Chief, Section of Urology

Arizona Health Sciences Center
Department of Surgery, Rm. 6233
1501 N. Campbell Avenue
PO Box 245077
Tucson, AZ 85724-5077

Office Phone: (520) 626-6895
Office Fax:(520) 626-4933
Appointments: (520) 694-4032
Email: sokoloff@surgery.arizona.edu

Mitchell H. Sokoloff, MD

Education
MD:	1991 - Stanford University School of Medicine
Residency:	1991-1997 - Department of Surgery, University of California Los Angeles
Fellowship:	1997-1999 - Molecular Urology and Therapeutics, University of Virginia

Clinical Specialties
treatment of prostate, kidney, and testis cancer; robotic surgery

Board Certifications
American Board of Urology

Research
Combining novel and innovative drug therapies with conventional surgery to improve outcomes of patients with aggressive and high-risk, locally advanced and/or metastatic tumors.

Incorproation of minimally-invasive technology to the treatment of urologic cancers.

Selected Publications

Wagner, M, Sokoloff, MH, Daneshmand, S. The role of pelvic lymphadanectomy for prostate cancer: therapeutic? Journal of Urology; 2008, 179(2): 408-13
Buscarini, M, Conlin, M, Sokoloff, M. Laparoscopic partial nephrectomy. Minerva Urologia and Nefrologia, 2007, 59(1):89-97.
Sokoloff, MH, Joyce, GF, Wise, M. Testicular cancer: Report from the UDA Compendium of the Urologic Diseases in America Project. Journal of Urology. Journal of Urology, 2006, 177(6): 2030-41.
Ritch, CR, Brendler, CB, Wan, RL, Pickett, KE, Sokoloff, MH. Relationship of erythrocyte membrane polyunsaturated fatty acids and Prostate-specific antigen levels in Jamaican men. BJU International, 2004, 93(6):1211-1215.
Sokoloff, MH, Rinker-Schaeffer, CW, Chung, LWK, Brendler, CB. Adjunctive therapy for men with high risk localized and locally-advanced prostate cancer: targeting disseminated tumor cells. Journal of Urology, 2004, 172(6, Part 2 of 2):2539-44.